Position in LLY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$88,082,693
+$15,277,415 QoQ
Shares Held
95,766
+41.4% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Mar 31, 2026CallValue
$37,158,708
CallShares
40,400
PutValue
$19,775,055
PutShares
21,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Point72 Asset Management, L.P. holds $795,359,411 across 11 Drug Manufacturers - General names. LLY ranks #5 (11.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,233,965 | $243,362,577 | |
| 2 | BIIB |
Biogen Inc.
|
809,617 | $148,427,084 | |
| 3 | PFE |
Pfizer Inc
|
4,365,063 | $122,570,969 | |
| 4 | MRK |
Merck & Co., Inc.
|
921,077 | $110,796,352 | |
| 5 | LLY |
ELI LILLY & Co
This page
|
95,766 | $88,082,693 | |
| 6 | NVS |
Novartis AG
|
283,837 | $43,356,101 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
531,198 | $32,217,158 | |
| 8 | AMRN |
Amarin Corp Plc\Uk
|
240,761 | $3,481,404 |
All Filings in LLY
Export CSV
31 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19,775,055 | 21,500 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $88,082,693 | 95,766 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $37,158,708 | 40,400 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $94,034,508 | 87,500 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $72,805,278 | 67,746 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $30,735,850 | 28,600 | Put | Defined | 2026-02-17 | |
| 2025-09-30 | $4,578,000 | 6,000 | Call | Defined | 2025-11-14 | |
| 2025-09-30 | $3,433,500 | 4,500 | Put | Defined | 2025-11-14 | |
| 2025-09-30 | $5,431,797 | 7,119 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,507,885 | 4,500 | Put | Defined | 2025-08-14 | |
| 2025-06-30 | $2,494,496 | 3,200 | Call | Defined | 2025-08-14 | |
| 2025-06-30 | $146,949,200 | 188,510 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $35,596,721 | 43,100 | Call | Defined | 2025-07-21 | |
| 2025-03-31 | $45,238,394 | 54,774 | Shares | Defined | 2025-07-21 | |
| 2024-12-31 | $1,003,600 | 1,300 | Call | Defined | 2025-02-14 | |
| 2024-09-30 | $11,657,198 | 13,158 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $97,952,943 | 125,910 | Shares | Defined | 2024-05-15 | |
| 2024-03-31 | $17,115,120 | 22,000 | Put | Defined | 2024-05-15 | |
| 2023-12-31 | $1,165,840 | 2,000 | Put | Defined | 2024-02-14 | |
| 2023-12-31 | $99,802,316 | 171,211 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,074,260 | 2,000 | Put | Defined | 2023-11-14 | |
| 2023-09-30 | $98,094,977 | 182,628 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $43,109,579 | 91,922 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,519,633 | 4,425 | Shares | Defined | 2023-05-15 | |
| 2022-09-30 | $93,498,269 | 289,155 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,598,953 | 11,100 | Call | Defined | 2022-08-15 | |
| 2022-06-30 | $95,907,234 | 295,800 | Shares | Defined | 2022-08-15 | |
| 2021-12-31 | $77,424,466 | 280,300 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $20,124,455 | 87,100 | Shares | Defined | 2021-11-15 | |
| 2020-12-31 | $141,335,964 | 837,100 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $194,874,398 | 1,316,541 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||